AMENDMENT NO. 1 TO SERIES A-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT
Exhibit 10.67
AMENDMENT NO. 1
TO
SERIES A-1 CONVERTIBLE PREFERRED
STOCK PURCHASE AGREEMENT
This AMENDMENT NO. 1 TO SERIES A-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this Amendment No. 1) is entered into as of the 11th day of May, 2011, to amend that certain Series A-1 Convertible Preferred Stock Purchase Agreement dated April 25, 2011, by and among Radius Health, Inc., a Delaware corporation (the Corporation) and each of the Investor parties named therein. Capitalized terms used but not defined herein shall have the meaning ascribed thereto in the Agreement.
WHEREAS, the parties to the Agreement (the Parties) have entered into the Agreement for, among other things, the purchase and sale shares of the Corporations Series A-1 Preferred Stock;
WHEREAS, the Parties acknowledge and agree that it is in the best interest of the Parties to eliminate certain conditions precedent and subsequent to the Stage I Closing, Stage II Closing and the Stage III Closing, as set forth herein; and
WHEREAS, the Parties wish to amend the Agreement as set forth herein.
NOW, THEREFORE, in consideration of the agreements herein and in the Agreement and in reliance upon the representations and warranties herein and therein, the parties hereto, intending to be legally bound, hereby agree as follows:
1. Section 7.1 of the Agreement is hereby amended by deleting Section 7.1 in its entirety and replacing it with the following: 7.1 RESERVED.
2. Section 7.2 of the Agreement is hereby amended by deleting Section 7.2 in its entirety and replacing it with the following: 7.2 RESERVED.
3. Section 7.3 of the Agreement is hereby amended by deleting Section 7.3 in its entirety and replacing it with the following: 7.3 RESERVED.
4. Section 7.4 of the Agreement is hereby amended by deleting Section 7.4 in its entirety and replacing it with the following: 7.4 RESERVED.
5. Section 7.5 of the Agreement is hereby amended by deleting Section 7.5 in its entirety and replacing it with the following: 7.5 RESERVED.
6. Section 8 of the Agreement is hereby amended by deleting clause (c) thereof in its entirety, deleting ; and in the sixth line thereof and inserting and in the fifth line immediately before (b).
7. The Agreement is hereby amended by deleting all references to the sections of the Agreement deleted in their entirety hereby.
8. Except to the extent amended hereby, all of the definitions, terms, provisions and conditions set forth in the Agreement are hereby ratified and confirmed and shall remain in full force and effect. The Agreement and this Amendment No. 1 shall be read and construed together as a single agreement and the term Agreement shall be deemed a reference to the Agreement as amended by this Amendment No. 1. This Amendment No. 1 may be signed in any number of counterparts, each of which
shall be deemed to be an original and all of which together shall constitute but one and the same instrument. In making proof of this Amendment No. 1 it shall not be necessary to produce or account for more than one such counterpart.
IN WITNESS WHEREOF, the parties have executed under seal and delivered this Agreement as of the date first written above.
| THE CORPORATION: | |
|
| |
| RADIUS HEALTH, INC. | |
|
| |
| By: | /s/ C. Richard Edmund Lyttle |
|
| Name: C. Richard Edmund Lyttle |
|
| Title: President |
|
| |
|
| |
| As an anticipated successor and assign to the Corporation under Section 16 hereof: | |
|
| |
| MPM ACQUISITION CORP. | |
|
| |
|
| |
| By: | /s/ C. Richard Edmund Lyttle |
|
| Name: C. Richard Edmund Lyttle |
|
| Title: President |
| INVESTORS: | ||
|
| ||
| BB Biotech Ventures II, L.P. | ||
|
| ||
| By: | BB Biotech Ventures Guernsey Ltd | |
|
| Its General Partner | |
|
|
| |
| By: | /s/ Pascal Mahieux | |
|
| Name: Pascal Mahieux | |
|
| Title: Director | |
|
| ||
|
| ||
| BB Biotech Growth N.V. | ||
|
| ||
| By: | /s/ Jan Bootsma | |
|
| Name: Jan Bootsma | |
|
| Title: Managing Director | |
|
|
| |
| HEALTHCARE VENTURES VII, L.P. | ||
| By: | HealthCare Partners VII, L.P. | |
|
| Its General Partner | |
|
|
| |
| By: | /s/ Jeffrey Steinberg | |
|
| Name: | Jeffrey Steinberg |
|
| Title: | Administrative Partner of HealthCare Partners VII, L.P. |
|
|
| The General Partner of HealthCare Ventures VII, L.P. |
|
| ||
|
| ||
| HEALTHCARE PRIVATE EQUITY LIMITED PARTNERSHIP acting by its general partner Waverley Healthcare Private Equity Limited | ||
|
|
| |
|
|
| |
| By: | /s/ Andrew November | |
|
| Name: Andrew November | |
|
| Title: Authorized Signatory |
| MPM BIOVENTURES III, L.P. | |
|
| |
| By: | MPM BioVentures III GP, L.P., |
|
| its General Partner |
| By: | MPM BioVentures III LLC, |
|
| its General Partner |
|
| |
| By: | /s/ Ansbert Gadicke |
|
| Name: Ansbert Gadicke |
|
| Title: Series A Member |
|
| |
|
| |
| MPM BIOVENTURES III-QP, L.P. | |
|
| |
| By: | MPM BioVentures III GP, L.P., |
|
| its General Partner |
| By: | MPM BioVentures III LLC, |
|
| its General Partner |
|
|
|
| By: | /s/ Ansbert Gadicke |
|
| Name: Ansbert Gadicke |
|
| Title: Series A Member |
|
|
|
|
|
|
| MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG | |
|
| |
| By: | MPM BioVentures III GP, L.P., |
|
| in its capacity as the Managing |
|
| Limited Partner |
| By: | MPM BioVentures III LLC, |
|
| its General Partner |
|
| |
| By: | /s/ Ansbert Gadicke |
|
| Name: Ansbert Gadicke |
|
| Title: Series A Member |
| MPM BIOVENTURES III PARALLEL | |
| FUND, L.P. | |
|
| |
| By: | MPM BioVentures III GP, L.P., |
|
| its General Partner |
| By: | MPM BioVentures III LLC, |
|
| its General Partner |
|
|
|
| By: | /s/ Ansbert Gadicke |
|
| Name: Ansbert Gadicke |
|
| Title: Series A Member |
|
| |
|
| |
| MPM ASSET MANAGEMENT | |
| INVESTORS 2003 BVIII LLC | |
|
| |
| By: | /s/ Ansbert Gadicke |
|
| Name: Ansbert Gadicke |
|
| Title: Manager |
|
| |
|
| |
| MPM BIO IV NVS STRATEGIC FUND, L.P. | |
|
| |
| By: | MPM BioVentures IV GP LLC, |
|
| its General Partner |
| By: | MPM BioVentures IV LLC, |
|
| its Managing Member |
|
|
|
| By: | /s/ Ansbert Gadicke |
|
| Name: Ansbert Gadicke |
|
| Title: Member |
|
| |
|
| |
| SAINTS CAPITAL VI, L.P., | |
| a limited partnership | |
|
|
|
| By: | Saints Capital VI LLC, |
| a limited liability company | |
|
|
|
| By: | /s/ David P. Quinlivan |
|
| Name: David P. Quinlivan |
|
| Title: Managing Member |
| BROOKSIDE CAPITAL PARTNERS FUND, L.P. | |
|
|
|
|
|
|
| By: | /s/ Ranesh Ramanathan |
|
| Name: Ranesh Ramanathan |
|
| Title: General Counsel |
|
|
|
| The Breining Family Trust dated August 15, 2003 | |
|
|
|
|
|
|
| By: | /s/ Clifford Breining |
|
| Name: Clifford Breining |
|
| Title: Trustee |
|
|
|
| The Richman Trust dated 2/6/83 | |
|
|
|
|
|
|
| By: | /s/ Douglas Richman |
| Name: Douglas D. Richman | |
| Title: Co-Trustee | |
|
|
|
|
|
|
| By: | /s/ Eva A. Richman |
| Name: Eva A. Richman, | |
| Title: Co-Trustee | |
|
|
|
| THE WELLCOME TRUST LIMITED, AS TRUSTEE OF THE WELLCOME TRUST | |
|
| |
|
| |
| By: | /s/ Peter Pereira Gray |
| Name: Peter Pereira Gray | |
| Title: Managing Director | |
|
| |
| /s/ Raymond F. Schinazi | |
| Dr. Raymond F. Schinazi | |
|
|
|
| /s/ H. Watt Gregory III | |
| H. Watt Gregory III | |
|
| |
| The David E. Thompson Revocable Trust | |
|
| |
|
| |
| By: | /s/ David E. Thompson |
| Name: David E. Thompson | |
| Title: Trustee |